August 2017

Hope for families as MSAC delivers

Posted: 4/08/2017 10:09:07 AM
After a decade of lobbying and in response to a Genea submission, the Medical Services Advisory Committee (MSAC) has formally recommended the Federal Government provide funding for pre-implantation genetic diagnosis (PGD).

Media Contact

Alice Ross
M: 0421 741 737
E: alice.ross@genea.com.au

About Genea

Genea is one of Australia’s leading providers for infertility, IVF and other assisted conception treatment with 31 years of experience in the field. The company has long been a fertility pioneer, with research and technologies developed in-house virtually doubling IVF success rates in the mid-nineties and continuing to improve outcomes today. In September 2017, Genea was listed in the Australian Financial Review’s Top 50 Most Innovative Companies List, ranking number 25.